| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |